Is HCP Plastene overvalued or undervalued?

As of 20 June 2025, the valuation grade for HCP Plastene has moved from attractive to very attractive, indicating a significant positive shift in its perceived value. The company is currently assessed as undervalued, especially when considering its key financial ratios: a PE ratio of 18.95, an EV to EBITDA of 10.48, and a PEG ratio of 0.02, which suggests strong growth potential relative to its price.
In comparison to its peers, HCP Plastene's PE ratio is notably lower than Garware Hi Tech, which stands at 28.07, and TCPL Packaging at 23.12, both of which are categorized as expensive. Additionally, AGI Greenpac, another very attractive peer, has a PE of 15.64, further highlighting HCP Plastene's relative undervaluation. While the stock has experienced a decline of 6.08% over the past week, it has outperformed the Sensex with a year-to-date return of 10.13% compared to the Sensex's 5.46%.